Skip to main content
. 2024 Jul 19;14:1440650. doi: 10.3389/fonc.2024.1440650

Figure 1.

Figure 1

Human plasma-like media (HPLM) attenuates leukemia cell sensitivity to thiopurine chemotherapeutics. 6-MP (A–E) and 6-TG (F–J) dose-response curves for leukemia cells (NALM-6, A, F; REH, B, G; SEM, C, H; Jurkat, D, I; CEM, E, J) in regular or HPLM media. Leukemia cell viability was assessed after 48 hours of drug treatment using the CellTiter-Glo Luminescent Cell Viability Assay. Error bars represent the mean ± SD of three technical replicates.